Assessment of type I error rate associated with dose-group switching in a longitudinal Alzheimer trial.
Habteab Ghebretinsae, Aklilu
Assessment of type I error rate associated with dose-group switching in a longitudinal Alzheimer trial. [electronic resource] - Journal of biopharmaceutical statistics 2014 - 660-84 p. digital
Publication Type: Journal Article
1520-5711
10.1080/10543406.2014.888570 doi
Alzheimer Disease--drug therapy
Clinical Trials, Phase III as Topic--methods
Computer Simulation
Data Interpretation, Statistical
Dose-Response Relationship, Drug
Endpoint Determination--statistics & numerical data
Humans
Likelihood Functions
Longitudinal Studies
Models, Statistical
Patient Dropouts--statistics & numerical data
Randomized Controlled Trials as Topic--methods
Assessment of type I error rate associated with dose-group switching in a longitudinal Alzheimer trial. [electronic resource] - Journal of biopharmaceutical statistics 2014 - 660-84 p. digital
Publication Type: Journal Article
1520-5711
10.1080/10543406.2014.888570 doi
Alzheimer Disease--drug therapy
Clinical Trials, Phase III as Topic--methods
Computer Simulation
Data Interpretation, Statistical
Dose-Response Relationship, Drug
Endpoint Determination--statistics & numerical data
Humans
Likelihood Functions
Longitudinal Studies
Models, Statistical
Patient Dropouts--statistics & numerical data
Randomized Controlled Trials as Topic--methods